Legend Biotech: JPMorgan cuts target price to $33 from $35
LEGN•JPMorgan cut its target price for Legend Biotech to $33 from $35.
Related News
Dip in US yields, dollar lend RBI hand in slowing rupee's slide to all-time low
INDA•
L1 Capital reports AVR common share purchase valued at $1,958,950.10
AVR•
H.B. Fuller prices $850 million of 7.625% senior unsecured notes due 2034
FUL•
Honda publishes Honda Report 2026 integrated report
HMC•
Arista Networks CFO Chantelle Breithaupt sells 1,224 shares worth $263,160
ANET•